Haemonetics HAE
NYSE HAE
$117.23 +0.12 (+0.10%)
As of: Oct 22, 2026 · 12:42 PM EDT

Haemonetics (HAE) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Haemonetics (HAE) posted Liabilities and Shareholders Equity of $2.37 billion for fiscal Q1 2027 (quarter ended Jun 27, 2026), down 3.9% from $2.46 billion a year earlier and down 1.3% from the prior quarter.

Analysis

Haemonetics (HAE) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 28, 2026), Haemonetics' Liabilities and Shareholders Equity came in at $2.4 billion, down 2.2% from FY2025.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 5.7% (FY2021 to FY2026).
  • In prior fiscal years, Haemonetics' Liabilities and Shareholders Equity was $2.45 billion in FY2025 (+11.6%), $2.2 billion in FY2024 (+13.5%), $1.93 billion in FY2023 (+4.0%) and $1.86 billion in FY2022 (+2.2%).
  • The fiscal Q1 2027 figure stands as the lowest quarterly Liabilities and Shareholders Equity since fiscal Q4 2024.
  • On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last five quarters, with growth averaging 4.8% over the last eight quarters.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was fiscal Q3 2022, with growth of 38.9%; the weakest was fiscal Q1 2027, with a decline of 3.9%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior fiscal quarters was $2.4 billion (Q4 2026), $2.49 billion (Q3 2026) and $2.44 billion (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 251.52 Bn 230.54 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 177.51 Bn 147.94 Bn 7.27 Bn 109.22 Bn
3 Danaher 161.23 Bn 145.04 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 156.10 Bn 135.53 Bn 1.96 Bn 20.88 Bn
5 Medtronic 122.39 Bn 87.64 Bn 6.34 Bn 93.31 Bn
6 Stryker 117.95 Bn 104.06 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 66.97 Bn 61.74 Bn 3.85 Bn 45.22 Bn
8 Becton Dickinson 54.45 Bn 51.60 Bn 2.32 Bn 50.73 Bn
9 Edwards Lifesciences 51.41 Bn 35.42 Bn 1.35 Bn 13.87 Bn
10 Haemonetics 5.32 Bn 4.19 Bn 202.80 Mn 2.37 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 2.37 Bn
Mar 28, 2026 2.40 Bn
Dec 27, 2025 2.49 Bn
Sep 27, 2025 2.44 Bn
Jun 28, 2025 2.46 Bn
Mar 29, 2025 2.45 Bn
Dec 28, 2024 2.53 Bn
Sep 28, 2024 2.53 Bn
Jun 29, 2024 2.54 Bn
Mar 30, 2024 2.20 Bn
Dec 30, 2023 2.20 Bn
Sep 30, 2023 2.01 Bn
Jul 1, 2023 1.96 Bn
Apr 1, 2023 1.93 Bn
Dec 31, 2022 1.88 Bn
Oct 1, 2022 1.87 Bn
Jul 2, 2022 1.82 Bn
Apr 2, 2022 1.86 Bn
Jan 1, 2022 1.83 Bn
Oct 2, 2021 1.80 Bn
API Access

Haemonetics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=HAE&period=max&api_key=YOUR_API_KEY